{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:21:39Z","timestamp":1787757699303,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The prevalence of hydrocephalus among patients with neurofibromatosis type I (NF1) is estimated to be between 1 and 13%. Aqueductal webs, chiasmatic-hypothalamic tumors, and thalamic mass effect related to NF changes are the common causes of NF1-related hydrocephalus. Brain tumors and moyamoya syndrome may mimic the clinical presentation of hydrocephalus in children with NF1, and should be ruled out while evaluating children with headaches. Treatment of NF1-related hydrocephalus should be personally tailored, including shunts, endoscopic procedures such as septostomy and third ventriculostomy, and tumor resection or debulking. Despite these personalized treatments, many of the primary treatments (including shunts and endoscopic procedures) fail, and patients should be screened and followed accordingly. In the current manuscript, we review the causes of NF1-related hydrocephalus, as well as treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.332254","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T01:37:09Z","timestamp":1640655429000},"page":"S372-S375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Neurofibromatosis Type 1 Related Hydrocephalus"],"prefix":"10.4103","volume":"69","author":[{"given":"Jonathan","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Constantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240907","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ped.13388","article-title":"Neurological comorbidity in children with neurofibromatosis type 1","volume":"60","author":"Hirabaru","year":"2018","journal-title":"Pediatr Int"},{"key":"R2-19-20240907","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1526-4610.1996.3601010.x","article-title":"Headache in patients with neurofibromatosis type 1","volume":"36","author":"Clementi","year":"1996","journal-title":"Headache"},{"key":"R3-19-20240907","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/brain\/122.3.473","article-title":"Neurological complications of neurofibromatosis type 1 in adulthood","volume":"122","author":"Creange","year":"1999","journal-title":"Brain"},{"key":"R4-19-20240907","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3174\/ajnr.A2357","article-title":"Hydrocephalus in patients with neurofibromatosis type 1: MR imaging findings and the outcome of endoscopic third ventriculostomy","volume":"32","author":"Dincer","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"R5-19-20240907","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1227\/00006123-198612000-00024","article-title":"Neurofibromatosis presenting with aqueductal stenosis due to a tumor of the aqueduct: Case report","volume":"19","author":"Hosoda","year":"1986","journal-title":"Neurosurgery"},{"key":"R6-19-20240907","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.wneu.2017.08.053","article-title":"Endoscopic third ventriculostomy in patients with neurofibromatosis type 1: A multicenter international experience","volume":"107","author":"Roth","year":"2017","journal-title":"World Neurosurg"},{"key":"R7-19-20240907","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/088307388800300210","article-title":"Aqueductal stenosis and neurofibromatosis: A rare association","volume":"3","author":"Afifi","year":"1988","journal-title":"J Child Neurol"},{"key":"R8-19-20240907","first-page":"322","article-title":"Periaqueductal gliosis causing hydrocephalus in a patient with neurofibromatosis type 1","volume":"2","author":"Balestrazzi","year":"1989","journal-title":"Neurofibromatosis"},{"key":"R9-19-20240907","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4103\/0028-3886.193836","article-title":"Rare case of non-neoplastic aqueductal stenosis due to web in a patient with neurofibromatosis type-1","volume":"64","author":"Garg","year":"2016","journal-title":"Neurol India"},{"key":"R11-19-20240907","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.wneu.2019.04.231","article-title":"Neurofibromatosis type 1-related hydrocephalus: Treatment options and considerations","volume":"128","author":"Roth","year":"2019","journal-title":"World Neurosurg"},{"key":"R12-19-20240907","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028922","article-title":"Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1","volume":"32","author":"Allen","year":"2000","journal-title":"Pediatr Neurosurg"},{"key":"R13-19-20240907","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.46.6.1652","article-title":"The management of brainstem gliomas in patients with neurofibromatosis 1","volume":"46","author":"Pollack","year":"1996","journal-title":"Neurology"},{"key":"R14-19-20240907","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1227\/00006123-198901000-00017","article-title":"Association of von Recklinghausen's neurofibromatosis and aqueduct stenosis","volume":"24","author":"Senveli","year":"1989","journal-title":"Neurosurgery"},{"key":"R15-19-20240907","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00381-017-3370-9","article-title":"Altered cerebrospinal fluid dynamics in neurofibromatosis type l: severe arachnoid thickening in patients with neurofibromatosis type 1 may cause abnormal CSF dynamic","volume":"33","author":"Kang","year":"2017","journal-title":"Childs Nerv Syst"},{"key":"R16-19-20240907","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: A multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"key":"R17-19-20240907","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/08880018.2017.1360971","article-title":"Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition","volume":"34","author":"Bavle","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R18-19-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2013.8.PEDS12546","article-title":"The role of surgery in optic pathway\/hypothalamic gliomas in children","volume":"13","author":"Goodden","year":"2014","journal-title":"J Neurosurg Pediatr"},{"key":"R19-19-20240907","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","article-title":"Optic pathway gliomas: A review","volume":"23","author":"Binning","year":"2007","journal-title":"Neurosurg Focus"},{"key":"R20-19-20240907","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.wneu.2016.02.042","article-title":"Treatment and outcome in 65 children with optic pathway gliomas","volume":"89","author":"El Beltagy","year":"2016","journal-title":"World Neurosurg"},{"key":"R21-19-20240907","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08880010050120818","article-title":"Visual pathway tumors and hydrocephalus","volume":"17","author":"Shuper","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"R22-19-20240907","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s003810100460","article-title":"Ascites following ventriculoperitoneal shunting in children with chiasmatic-hypothalamic glioma","volume":"17","author":"Gil","year":"2001","journal-title":"Childs Nerv Syst"},{"key":"R23-19-20240907","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3171\/2016.10.PEDS16352","article-title":"Initial experience with endoscopic ultrasonic aspirator in purely neuroendoscopic removal of intraventricular tumors","volume":"19","author":"Cinalli","year":"2017","journal-title":"J Neurosurg Pediatr"},{"key":"R24-19-20240907","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00381-015-2787-2","article-title":"Stented endoscopic third ventriculostomy-indications and results","volume":"31","author":"Schulz","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"R25-19-20240907","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/2152-7806.154467","article-title":"Endoscopic considerations treating hydrocephalus caused by basal ganglia and large thalamic tumors","volume":"6","author":"Roth","year":"2015","journal-title":"Surg Neurol Int"},{"key":"R26-19-20240907","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s002340050484","article-title":"Neurofibromatosis type 1: Brain stem tumours","volume":"39","author":"Bilaniuk","year":"1997","journal-title":"Neuroradiology"},{"key":"R27-19-20240907","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.45.10.1897","article-title":"Brainstem tumors in patients with neurofibromatosis type 1: A distinct clinical entity","volume":"45","author":"Molloy","year":"1995","journal-title":"Neurology"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.332254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:50:37Z","timestamp":1787755837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.332254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.332254","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}